APPLIED GENETIC TECHNOL CORP's ticker is AGTC and the CUSIP is 03820J100. A total of 69 filers reported holding APPLIED GENETIC TECHNOL CORP in Q4 2020. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $31,000 | -67.7% | 115,100 | -7.6% | 0.00% | – |
| Q2 2022 | $96,000 | -29.9% | 124,500 | -2.5% | 0.00% | – |
| Q1 2022 | $137,000 | -43.6% | 127,700 | -0.0% | 0.00% | – |
| Q4 2021 | $243,000 | -38.5% | 127,726 | -2.7% | 0.00% | – |
| Q3 2021 | $395,000 | -30.2% | 131,300 | -9.3% | 0.00% | – |
| Q2 2021 | $566,000 | -25.3% | 144,790 | -3.2% | 0.00% | – |
| Q1 2021 | $758,000 | +39.9% | 149,591 | +12.9% | 0.00% | – |
| Q4 2020 | $542,000 | -20.4% | 132,500 | -5.5% | 0.00% | – |
| Q3 2020 | $681,000 | -14.2% | 140,200 | -2.3% | 0.00% | – |
| Q2 2020 | $794,000 | +89.5% | 143,428 | +12.4% | 0.00% | – |
| Q1 2020 | $419,000 | +1002.6% | 127,628 | +1160.2% | 0.00% | – |
| Q2 2019 | $38,000 | -9.5% | 10,128 | 0.0% | 0.00% | – |
| Q1 2019 | $42,000 | +68.0% | 10,128 | 0.0% | 0.00% | – |
| Q4 2018 | $25,000 | -66.2% | 10,128 | 0.0% | 0.00% | – |
| Q3 2018 | $74,000 | +100.0% | 10,128 | 0.0% | 0.00% | – |
| Q2 2018 | $37,000 | -14.0% | 10,128 | -15.6% | 0.00% | – |
| Q4 2017 | $43,000 | – | 12,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERWEST VENTURE MANAGEMENT CO | 1,404,515 | $1,081,000 | 2.01% |
| SABBY MANAGEMENT, LLC | 811,973 | $625,000 | 0.42% |
| Portolan Capital Management | 1,605,599 | $1,236,000 | 0.12% |
| Knoll Capital Management, LLC | 100,000 | $77,000 | 0.04% |
| Shay Capital LLC | 50,000 | $39,000 | 0.01% |
| COLONY GROUP LLC | 330,287 | $254,000 | 0.00% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 155,375 | $120,000 | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 1,499,124 | $1,154,000 | 0.00% |
| Virtu Financial LLC | 10,807 | $8,000 | 0.00% |
| FIDUCIARY TRUST CO | 40,000 | $31,000 | 0.00% |